How to Purchase Life Insurance for Cancer Patients [8 Tips for Coverage]

Life Insurance Tips For Specific Cancers

Not all cancers are looked at the same. Even specific cancers are looked at differently depending on their stage and other factors.

Breast Cancer

Life insurance after breast cancer is possible. Life insurance insurers will want to know if your breast cancer is in full remission or not. Your agent will want to shop your case based on when your breast cancer was diagnosed, the treatment type, and length of remission time.

Basal Cell Carcinoma

Basal cell is the most common and harmless form of skin cancer. It typically is not an issue with life insurance companies.


The most severe type of skin cancer is Melanoma. However, life insurance after melanoma is possible. One of the things insurance companies want to be sure about is that the melanoma has not metastasized. You should be approved for life insurance if your melanoma has been surgically removed and you’ve been in remission for 12-24 months. It is a bit more complicated if your treatment involved radiation or chemotherapy. You’re looking at possibly 5 years or more depending on the carrier.

Squamous Cell Carcinoma

Squamous cell carcinoma is typically the 2nd tier of skin cancer severity. It’s looked at a little more severely compared to basal cell and less severe compared to Melanoma. If your squamous cell hasn’t spread in the past 12 to 24 months, you can typically get approved at standard rates.

Prostate Cancer

Life insurance after prostate cancer is possible. Life insurance companies will want to know your PSA levels and Gleason scores before making a decision on your case. The Prostate Specific Antigen (PSA) levels and Gleason scores will be looked at differently from each company. The carriers will also want to know how long you’ve been in remission after your prostate cancer treatment. They may also want to see that you’ve had follow up testing and received continuous care from your physician. 

Leave a Reply

Your email address will not be published.